menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Successful Treatment of MDR and XDR-TB

close
Successful Treatment of MDR and XDR-TB
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Since it was first described by international health organizations in 2006, extensively drug-resistant tuberculosis has been documented in 49 countries. In addition, more than 80 countries are coping with multi-drug resistant tuberculosis. How are we addressing the rapid emergence of these significant threats to tuberculosis treatment and control programs across the world? In which countries are we seeing significant progress in treating both forms of tuberculosis? Dr. Sonya Shin, assistant professor of medicine at Harvard Medical School, contours lessons for the global struggle against TB from her work in South America and Asia with host Dr. Mark Nolan Hill.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Since it was first described by international health organizations in 2006, extensively drug-resistant tuberculosis has been documented in 49 countries. In addition, more than 80 countries are coping with multi-drug resistant tuberculosis. How are we addressing the rapid emergence of these significant threats to tuberculosis treatment and control programs across the world? In which countries are we seeing significant progress in treating both forms of tuberculosis? Dr. Sonya Shin, assistant professor of medicine at Harvard Medical School, contours lessons for the global struggle against TB from her work in South America and Asia with host Dr. Mark Nolan Hill.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 5/31/20